Blog
RSS FeedPosted by Michael Wonder on 12 Aug 2022
NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
12 August 2022 - Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens ...
Posted by Michael Wonder on 15 Jul 2022
UK lags behind EU in authorising new medicines after Brexit
14 July 2022 - Experts attribute shortfall to small size of British market now it is regulated separately and complexity of ...
Posted by Michael Wonder on 14 Jul 2022
Breakthrough treatment to boost life chances for hundreds of people with respiratory cancer
14 July 2022 - The first new mesothelioma treatment to be approved in nearly 15 years will be made available ...
Posted by Michael Wonder on 14 Jul 2022
Thousands of patients to benefit as NHS marks 100th fast tracked cancer drug
14 July 2022 - Thousands of people a year with advanced breast cancer will benefit from a life extending drug ...
Posted by Michael Wonder on 16 Jun 2022
NHS lands breakthrough in global battle against superbugs
15 June 2022 - The NHS is set to roll out two ‘superbug’ busting drugs through a world first, pioneering ...
Posted by Michael Wonder on 07 Jun 2022
Response to engagement on proposals for the Innovative Medicines Fund
7 June 2022 - NHS England and NICE asked for comments on our proposals for the Innovative Medicines Fund. ...
Posted by Michael Wonder on 07 Jun 2022
Patients to have earlier access to cutting edge treatments on NHS
7 June 2022 - The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund ...
Posted by Michael Wonder on 24 May 2022
NICE doesn’t recommend ibrutinib for those with Waldenstrom’s macroglobulinaemia
23 May 2022 - Ibrutinib, a drug used to treat Waldenström’s macroglobulinaemia, is not being recommended by NICE in England ...
Posted by Michael Wonder on 14 May 2022
Hundreds of patients to get life-extending lung cancer drug on the NHS
13 May 2022 - Hundreds of people with a form of the most common form of lung cancer could survive ...
Posted by Michael Wonder on 13 May 2022
NHS patients missing out on new medicines that could extend lives
13 May 2022 - Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are ...
Posted by Michael Wonder on 08 May 2022
NHS rolls out life-saving arthritis drug to treat COVID
5 May 2022 - The NHS is rolling out a cutting-edge, life-saving COVID treatment from today, which is proven to ...
Posted by Michael Wonder on 13 Apr 2022
Highest risk COVID-19 patients receive ‘brilliant’ new antivirals at home
9 April 2022 - Thousands of patients with COVID-19 who are most likely to be admitted to hospital are receiving ...
Posted by Michael Wonder on 12 Apr 2022
NICE reaches important milestone in the UK’s efforts to tackle antimicrobial resistance
12 April 2022 - Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - are close to becoming the first to be ...
Posted by Michael Wonder on 20 Mar 2022
NHS fast tracks new ‘gamechanging’ drug for lung cancer
18 March 2022 - A targeted new drug for a rare and aggressive form of lung cancer will be fast-tracked ...
Posted by Michael Wonder on 16 Mar 2022
Life-extending injection for blood cancer available on the NHS
15 March 2022 - A life-extending injection for a fatal form of blood cancer will be available to around 350 ...